Synovus Financial Corp purchased a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) in the third quarter, Holdings Channel.com reports. The firm purchased 8,866 shares of the medical instruments supplier’s stock, valued at approximately $240,000.
Several other institutional investors and hedge funds have also made changes to their positions in the business. First Eagle Investment Management LLC raised its position in shares of DENTSPLY SIRONA by 33.6% during the 2nd quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock worth $325,571,000 after acquiring an additional 3,283,965 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in DENTSPLY SIRONA by 42.0% during the second quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock worth $110,118,000 after purchasing an additional 1,308,411 shares in the last quarter. Cooke & Bieler LP lifted its position in shares of DENTSPLY SIRONA by 16.2% during the 2nd quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock worth $186,996,000 after buying an additional 1,046,105 shares during the last quarter. Invenomic Capital Management LP acquired a new position in shares of DENTSPLY SIRONA in the 3rd quarter valued at $23,724,000. Finally, National Bank of Canada FI grew its position in shares of DENTSPLY SIRONA by 684.6% in the 2nd quarter. National Bank of Canada FI now owns 876,400 shares of the medical instruments supplier’s stock valued at $21,586,000 after buying an additional 764,700 shares during the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of equities research analysts recently weighed in on XRAY shares. Evercore ISI reduced their price target on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th. Leerink Partnrs downgraded DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. Leerink Partners downgraded DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, November 7th. Mizuho initiated coverage on DENTSPLY SIRONA in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 price objective for the company. Finally, Needham & Company LLC decreased their price objective on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a report on Friday, October 25th. Eight research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, DENTSPLY SIRONA has an average rating of “Hold” and a consensus price target of $27.91.
DENTSPLY SIRONA Price Performance
DENTSPLY SIRONA stock opened at $18.68 on Thursday. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The business has a 50 day simple moving average of $21.07 and a 200-day simple moving average of $24.04. DENTSPLY SIRONA Inc. has a 12 month low of $17.21 and a 12 month high of $37.60. The stock has a market capitalization of $3.71 billion, a PE ratio of -9.02, a price-to-earnings-growth ratio of 1.93 and a beta of 0.96.
DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. The company had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. DENTSPLY SIRONA’s quarterly revenue was up .4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.49 EPS. Equities analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.
DENTSPLY SIRONA Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 10th. Shareholders of record on Friday, December 27th will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 3.43%. The ex-dividend date of this dividend is Friday, December 27th. DENTSPLY SIRONA’s dividend payout ratio is presently -30.92%.
DENTSPLY SIRONA Profile
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Read More
- Five stocks we like better than DENTSPLY SIRONA
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- What is the Dogs of the Dow Strategy? Overview and Examples
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.